<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="109139">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01746264</url>
  </required_header>
  <id_info>
    <org_study_id>12-006349</org_study_id>
    <nct_id>NCT01746264</nct_id>
  </id_info>
  <brief_title>Effect of Vitamin D Supplementation on Endothelial Function in Obese Adolescents</brief_title>
  <official_title>Effect of Vitamin D Supplementation on Endothelial Function in Obese Adolescents</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Vitamin D deficiency has been linked to endothelial dysfunction in adults. Obese adolescents
      have a high prevalence of Vitamin D deficiency as well as evidence of endothelial
      dysfunction. Our hypothesis is that supplementation of Vitamin D deficient adolescents with
      Vitamin D would lead to improvement in endothelial dysfunction.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2012</start_date>
  <completion_date type="Actual">December 2013</completion_date>
  <primary_completion_date type="Actual">December 2013</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <study_design>Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>Change in flow mediated dilatation (FMD)</measure>
    <time_frame>baseline to 3 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Endothelial function will be assessed by FMD.  Flow mediated dilatation (FMD) will be calculated as the maximal percentage increase in Brachial artery diameter (BAD) from baseline after the release of cuff occlusion.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">19</enrollment>
  <condition>Obesity</condition>
  <condition>Endothelial Dysfunction</condition>
  <condition>Vitamin D Deficiency</condition>
  <arm_group>
    <arm_group_label>Vitamin D</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Vitamin D supplementation at 100,000 IU once a month for 3 months</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Vitamin D3</intervention_name>
    <description>Vitamin D 3 at 100,000 IU once a month for 3 months</description>
    <arm_group_label>Vitamin D</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age 12-18 years

          2. BMI &gt;95% for age and gender

          3. 25 (OH) D levels less than 30 ng/ml

        Exclusion Criteria:

          1. 25 (OH) D levels  &gt;30 ng/mL

          2. Serum calcium &gt;10.4 mg/dL

          3. Serum phosphorus &gt; 4.7 mg/dl

          4. Pregnancy or nursing

          5. Current cancer

          6. Patients on vitamin D3 supplementation exceeding 400 IU/day

          7. Hypertension defined as Blood Pressure over the 95th percentile for age, gender and
             height

          8. Dietary calcium intake exceeding 1500 mg/day,

          9. Hepatic or renal disorders

         10. Type 1 or type 2 diabetes mellitus

         11. Subjects receiving insulin, metformin, or oral hypoglycemic medications

         12. Subjects with malabsorption disorders (celiac disease, cystic  fibrosis,inflammatory
             bowel disease)
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Seema Kumar, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 31, 2014</lastchanged_date>
  <firstreceived_date>November 16, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Seema Kumar</investigator_full_name>
    <investigator_title>PI</investigator_title>
  </responsible_party>
  <keyword>Obesity</keyword>
  <keyword>Endothelial dysfunction</keyword>
  <keyword>Vitamin D deficiency</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Vitamin D Deficiency</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Cholecalciferol</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Vitamins</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
